Close mobile menu×
Close mobile menu

Michael B. Collins, MD

Board Certifications: 
Internal Medicine, Cardiovascular Disease
Not Accepting New Patients
Profile Headshot

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease

Clinical Expertise

  • Angioplasty
  • Balloon Angioplasty of Artery
  • Cardiac Catheterization
  • Coronary Angioplasty
  • Coronary Artery Disease
  • Coronary Interventions
  • Heart Attack
  • Interventional Cardiology
  • Stents

Education & Training

  • New York Medical College
  • Residency: Nassau County Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center

About Michael Collins

Michael B. Collins, MD is an Interventional Cardiologist at the Center for Interventional Vascular Therapy, the Associate Director of the Cardiovascular Catheterization Lab at Columbia University Medical Center/NewYork-Presbyterian Hospital and Assistant Professor at Columbia University College of Physicians and Surgeons.

Dr. Collins specializes in complex percutaneous coronary interventions.

Dr. Collins received his medical degree in 1975 from Yale University School of Medicine, New Haven, Connecticut.

Academic Titles

  • Associate Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
New York, New York 10032
Primary

Research

Grants

BIOTRONIK - A PROSPECTIVE MULTICENTER STUDY TO CONFIRM THE SAFETY AND EFFECTIVENESS OF THE ORSIRO SIROLIMUS ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF SUBJECTS WITH UP TO THREE DE NOVO OR RESTENOTIC CORONARY ARTERY LESIONS - VII (P&S Industry Clinical Trial)

May 21 2020 - May 21 2025

SPIRIT IV:CLINICAL EVALUATION OF XIENCE V EVEROLIMUS ELUTINGCORONARY STENT SYSTEM IN TREATMENT OF CORONARY ARTERY LESION (P&S Industry Clinical Trial)

Aug 9 2006 - Jun 23 2013

ABIOMED -- G050017 (P&S Industry Clinical Trial)

Apr 10 2008 - Dec 31 2012

SPIRIT III:CLINICAL EVALUATION OF THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM IN THE TREATMENT OF SUBJECTS (P&S Industry Clinical Trial)

Jun 2 2005 - Dec 31 2012

CO-STAR II: COBALT CHROMIUM STENT WITH ANTIPROLIFERATIVE FORRESTENOSIS II TRIAL (P&S Industry Clinical Trial)

Jun 8 2005 - Dec 31 2011

PROTECT 1: A PROSPECTIVE FEASIBILITY TRIAL INVESTIGATING THE USE OF THE IMPELLA RECOVER LP 2.5 SYSTEM IN PTS (P&S Industry Clinical Trial)

Oct 18 2006 - Apr 30 2009